A PEG ratio for RGEN is not computable at this time - the current PE ratio is not available. Historical data from June 2026 shows Repligen with a PEG ratio of 0.47.
Repligen's ten years historical PEG ratio averages out to 5.75. RGEN reached its maximum PEG ratio of 58.47 during the Sep 2025 quarter over the past ten years. The Sep 2017 quarter had the bottom reading at 0.32, indicating the most optimal growth-adjusted valuation.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.65 | 188.34 | 289.1% |
| 2024 | N/A | N/A | -171.9% |
| 2023 | N/A | 280.94 | -80.9% |
| 2022 | 1.15 | 50.54 | 43.8% |
| 2021 | 1.09 | 113.67 | 104.4% |
| 2020 | 1.06 | 168.1 | 159.1% |
| 2019 | 13.31 | 210.23 | 15.8% |
| 2018 | N/A | 138.79 | -48.6% |
| 2017 | 0.44 | 49.03 | 111.4% |
| 2016 | 3.52 | 88.06 | 25% |
| 2015 | 8.42 | 101.04 | 12% |
| 2014 | N/A | 79.2 | -51% |
| 2013 | 2.45 | 26.75 | 10.9% |
| 2012 | N/A | 13.65 | N/A |
| 2011 | N/A | N/A | 100% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Sep 2026 | N/A | N/A | -1,100% |
| Jun 2026 | 0.47 | 181.92 | 388.5% |
| Mar 2026 | 0.4 | 128.07 | 319% |
| Dec 2025 | 0.65 | 188.34 | 289.1% |
| Sep 2025 | 58.47 | 6,683.5 | 114.3% |
| Jun 2025 | N/A | N/A | -252.9% |
| Mar 2025 | N/A | N/A | -197.7% |
| Dec 2024 | N/A | N/A | -171.9% |
| Sep 2024 | N/A | N/A | -107.7% |
| Jun 2024 | N/A | 741.53 | -92.4% |
| Mar 2024 | N/A | 427.72 | -84.5% |
| Dec 2023 | N/A | 280.94 | -80.9% |
| Sep 2023 | N/A | 87.85 | -39.7% |
| Jun 2023 | N/A | 63.15 | -22.2% |
| Mar 2023 | 11.43 | 60.56 | 5.3% |
A PEG ratio is not computable for RGEN - the PE ratio data is negative or zero.
RGEN shows a 5-year average PEG ratio of 7.73.
The Sep 2025 quarter marked the ten years high at 58.47 for RGEN's PEG ratio.
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.